“momelotinib”的概念、定义、翻译、参考文献-科学参考

An orally bioavailable small-molecule inhibitor of Janus kinases 1 and 2 (JAK1/2) with potential antineoplastic activity. Momelotinib competes with JAK1/2 for ATP binding, which may result in inhibition of JAK1/2 activation, inhibition of the JAK-STAT signaling pathway, and so the induction of apoptosis and a reduction of tumor cell proliferation in JAK1/2-expressing tumor cells. JAK2 is the most common mutated gene in bcr-abl-negative myeloproliferative disorders; the JAK2V617F gain-of-function mutation involves a valine-to-phenylalanine modification at position 617. The JAK-STAT signaling pathway is a major mediator of cytokine activity and is often dysregulated in a variety of tumor cell types.

单词	momelotinib
释义	momelotinib An orally bioavailable small-molecule inhibitor of Janus kinases 1 and 2 (JAK1/2) with potential antineoplastic activity. Momelotinib competes with JAK1/2 for ATP binding, which may result in inhibition of JAK1/2 activation, inhibition of the JAK-STAT signaling pathway, and so the induction of apoptosis and a reduction of tumor cell proliferation in JAK1/2-expressing tumor cells. JAK2 is the most common mutated gene in bcr-abl-negative myeloproliferative disorders; the JAK2V617F gain-of-function mutation involves a valine-to-phenylalanine modification at position 617. The JAK-STAT signaling pathway is a major mediator of cytokine activity and is often dysregulated in a variety of tumor cell types.
随便看	pBCAR3 phosphopeptide-tetanus peptide vaccine pBCAR3/pIRS2-phosphopeptide-tetanus peptide vaccine pbi-shRNA STMN1 lipoplex PBN derivative OKN-007 PBTL CD19CAR-28 zeta PCA p-cadherin antagonist PF-03732010 P-cadherin inhibitor PCA062 P-cadherin-targeting agent PF-06671008 PCNSL PCOS PCR PC regimen PC-SPES PCV PCV regimen PD0325901 PD-1 PD-1 knockout autologous T lymphocytes PDGF PDGFR alpha/KIT mutant-specific inhibitor BLU-285 PDK1 inhibitor AR-12 p.DOM-WT1-126 DNA vaccine p.DOM-WT1-37 DNA vaccine peak exposure